Stay updated on DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial
Sign up to get notified when there's something new on the DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial page.

Latest updates to the DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include the term 'Gastrointestinal Stromal Tumors' and the study identifier 'DCC-2618-03-001', while the previous version's detailed study description and inclusion/exclusion criteria have been removed. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference32%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial page.